Dorothee Selimoglu-Buet
Overview
Explore the profile of Dorothee Selimoglu-Buet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marchand V, Laplane L, Valensi L, Plo I, Aglave M, Silvin A, et al.
iScience
. 2025 Jan;
28(1):111522.
PMID: 39811665
Elevated circulating levels of calprotectin (CAL), the S100A8/A9 heterodimer, are biomarkers of severe systemic inflammation. Here, we investigate the effects of CAL on early human hematopoiesis. CAL demonstrates limited impact...
2.
Hidaoui D, Porquet A, Chelbi R, Bohm M, Polyzou A, Alcazer V, et al.
Commun Biol
. 2024 Nov;
7(1):1555.
PMID: 39578583
Chronic myelomonocytic leukemia (CMML) is a severe myeloid malignancy affecting the elderly, for which therapeutic options are limited. DNA hypomethylating agents (HMAs) provide transient responses, failing to eradicate the malignant...
3.
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia
Deschamps P, Wacheux M, Gosseye A, Morabito M, Pages A, Lyne A, et al.
J Clin Invest
. 2024 Nov;
134(22).
PMID: 39545419
Chronic myelomonocytic leukemia (CMML) is a severe myeloid malignancy with limited therapeutic options. Single-cell analysis of clonal architecture demonstrates early clonal dominance with few residual WT hematopoietic stem cells. Circulating...
4.
Ruffle F, Reboul J, Boureux A, Guibert B, Bessiere C, Silva R, et al.
NAR Genom Bioinform
. 2024 Sep;
6(3):lqae117.
PMID: 39318504
RNA sequencing technology combining short read and long read analysis can be used to detect chimeric RNAs in malignant cells. Here, we propose an integrated approach that uses k-mers to...
5.
Tarfi S, Kern W, Goulas E, Selimoglu-Buet D, Wagner-Ballon O
Cytometry B Clin Cytom
. 2024 Apr;
106(3):203-215.
PMID: 38656036
The monocyte subset partitioning by flow cytometry, known as "monocyte assay," is now integrated into the new classifications as a supporting criterion for CMML diagnosis, if a relative accumulation of...
6.
Tran Quang V, Podvin B, Desterke C, Tarfi S, Barathon Q, Badaoui B, et al.
Haematologica
. 2023 Apr;
108(11):3135-3141.
PMID: 37102610
No abstract available.
7.
Allouch A, Voisin L, Zhang Y, Raza S, Lecluse Y, Calvo J, et al.
Nat Commun
. 2022 Nov;
13(1):6739.
PMID: 36347876
Targeting the reprogramming and phagocytic capacities of tumor-associated macrophages (TAMs) has emerged as a therapeutic opportunity for cancer treatment. Here, we demonstrate that tumor cell phagocytosis drives the pro-inflammatory activation...
8.
Pronier E, Imanci A, Selimoglu-Buet D, Badaoui B, Itzykson R, Roger T, et al.
Commun Biol
. 2022 Feb;
5(1):110.
PMID: 35115654
Somatic mutation in TET2 gene is one of the most common clonal genetic events detected in age-related clonal hematopoiesis as well as in chronic myelomonocytic leukemia (CMML). In addition to...
9.
Sevin M, Debeurme F, Laplane L, Badel S, Morabito M, Newman H, et al.
Blood
. 2021 Mar;
137(24):3390-3402.
PMID: 33690800
Mouse models of chronic myeloid malignancies suggest that targeting mature cells of the malignant clone disrupts feedback loops that promote disease expansion. Here, we show that in chronic myelomonocytic leukemia...
10.
Jestin M, Tarfi S, Duchmann M, Badaoui B, Freynet N, Tran Quang V, et al.
Leukemia
. 2020 Jul;
35(3):893-896.
PMID: 32684630
No abstract available.